Ingevity Co. (NYSE:NGVT) Stock Position Decreased by Vanguard Group Inc.

Vanguard Group Inc. lowered its holdings in Ingevity Co. (NYSE:NGVT) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,164,419 shares of the company’s stock after selling 46,092 shares during the period. Vanguard Group Inc. owned about 0.11% of Ingevity worth $169,700,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. KLP Kapitalforvaltning AS acquired a new stake in shares of Ingevity during the 4th quarter worth approximately $4,882,000. Sei Investments Co. grew its stake in Ingevity by 23.4% during the 4th quarter. Sei Investments Co. now owns 235,854 shares of the company’s stock worth $9,611,000 after buying an additional 44,782 shares during the last quarter. American Century Companies Inc. increased its position in Ingevity by 37.7% in the fourth quarter. American Century Companies Inc. now owns 1,457,365 shares of the company’s stock worth $59,388,000 after buying an additional 398,800 shares during the period. Teacher Retirement System of Texas bought a new stake in Ingevity in the fourth quarter valued at $237,000. Finally, Trillium Asset Management LLC boosted its holdings in shares of Ingevity by 51.2% during the fourth quarter. Trillium Asset Management LLC now owns 114,925 shares of the company’s stock valued at $4,684,000 after acquiring an additional 38,896 shares during the period. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have issued reports on NGVT shares. BMO Capital Markets raised shares of Ingevity from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $62.00 to $65.00 in a research note on Wednesday, February 26th. StockNews.com raised Ingevity from a “hold” rating to a “buy” rating in a report on Friday. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $55.17.

Ingevity Trading Down 9.5 %

Shares of NYSE:NGVT opened at $31.37 on Monday. The company has a 50 day moving average of $44.11 and a 200-day moving average of $42.56. The company has a current ratio of 1.87, a quick ratio of 1.04 and a debt-to-equity ratio of 6.86. The firm has a market cap of $1.14 billion, a P/E ratio of -2.65 and a beta of 1.52. Ingevity Co. has a twelve month low of $30.13 and a twelve month high of $56.30.

Ingevity (NYSE:NGVT) last issued its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.66. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. The firm had revenue of $298.80 million during the quarter, compared to analyst estimates of $297.40 million. As a group, analysts anticipate that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.